Summary. The 
Introduction
Lactation in the pig is a period which is usually associated with anoestrus and anovulation. Weaning the piglets results in a rapid increase in follicular growth which terminates in overt oestrus and ovulation some 5-10 days later (Burger, 1952) . A proportion of sows, however, fail to show oestrus for a much longer period after weaning and thus decrease the productive efficiency of the herd. A large degree of variation in the weaning to oestrus interval in a herd results in reduced productivity because good conception rates require good service management which is not possible when service procedures interfere with other stock tasks. The variation in the weaning to oestrus interval is increased as duration of lactation is shortened (Self & Grummer, 1958 ; Smidt, Scheven & Steinbach, 1965; van der Heyde, 1972; Cole, Varley & Hughes, 1975) . Exogenous hormone therapy as a means of inducing oestrus during lactation has had limited success and has often involved a series of injections which is both time consuming and impractical (Cole & Hughes, 1946 ; Heitman & Cole, 1956;  Crighton, 1970; Guthrie, Pursel & Frobish, 1978) . The treatment of sows with gonadotrophins and steroids at, or shortly after, weaning has been more successful. Weaning to oestrus intervals have been shortened by use of diethylstilboestrol (Rigor, Villareal & Illagan, 1968) or a combination of steroids (Schmidt, Jochle & Thume, 1968 ; Dyck, Palmer & Simarks, 1979) but conception rates and litter size were reduced. Gonadotrophin therapy (PMSG : hCG combina¬ tions) can shorten the weaning to oestrus interval with no detrimental effects on fertility (Rasbech, 1953; Whyte, 1977) .
In this study we examined the effects of using oestradiol benzoate in weaned sows as a substitute for the naturally occurring rise in oestrogens which occurs before oestrus (Edwards & Foxcroft, 1983) 
Assay procedures
Blood samples were analysed for LH (Foxcroft, Pomerantz & Nalbandov, 1975) , FSH and oestradiol-17ß (Foxcroft, Elsaesser, Stickney, Back & Haynes, 1983) and progesterone (Haresign, Foster, Haynes, Crighton & Lamming, 1975) by previously validated radioimmunoassays. Interand intra-assay coefficients of variation (CV) were 12 and 6% and 15 and 4% for LH and FSH respectively. Inter-and intra-assay CVs for oestradiol-17ß were < 10% with an average recovery of steroid from plasma of 94-7 ± 0-8%. Oestradiol values were not corrected for recovery losses. Interand intra-assay CVs for progesterone were 10 and 14% and recovery of steroid from plasma averaged 65-5 ± 2-1% and values were corrected for recovery losses. Assay sensitivities (minimum detectable amount) were 1-0 ng LH/ml, 10 pg oestradiol-17ß/ml, 0-8 ng progesterone/ml and 30 ng FSH/ml.
Statistical analysis
All differences between means were analysed by Student's t test.
Results

Experiments 1 and 2
The injection of oestradiol benzoate on the day of weaning induced a very weak oestrus 3 days later as determined visually and with haunch testing. At slaughter the sows showed no evidence of ovulation and very little follicular development. Although analysis of the endocrine profiles from these sows showed that plasma FSH and LH concentrations did not rise at weaning, a highly synchronized preovulatory-type LH/FSH surge occurred. Mean ( + s.e.) LH peak levels of 12-4 ± 2-5 ng/ml were observed 63-3 ± 2 h after oestradiol benzoate and the duration of the surges ranged from 24 to 34 h. After the preovulatory FSH discharge, plasma FSH concentrations remained low until the end of the blood sampling period. Peak plasma levels of oestradiol were very high (285 ± 29 pg/ml) and were attained 27 ± 8 h after the injection of oestradiol benzoate ; concentrations declined to 40-50 pg/ml (still in the high physiological range) by 7 days after the injection. Plasma concentrations of progesterone were basal ( < 1 -0 ng/ml) throughout the sampling period.
One of the sows treated on Day 1 and the sow treated on Day 2 ovulated and formed 10 and 9 corpora lutea respectively. The remaining data from Exp. 2 are summarized in Table 1 (10-6 ± 1-1 in 3-week and 12-2 ± 1-7 in 5-week weaned animals).
A complete analysis of the endocrine profiles from 12 sows showed that plasma oestradiol levels after injection varied between 81 and 287 pg/ml (mean ± s.e.m. 158 ± 18 pg/ml) and reached a peak 3-47 (21 ± 4) h after injection (see Text-fig. 1 Progesterone concentrations were basal (< 1-5 ng/ml) in all sows in the days after weaning and began to rise on Day 6, indicating the onset of luteal function. This rise was strikingly synchronized and followed oestradiol benzoate injection by 100 ± 4 h. Throughout the remainder of the sampling period progesterone concentrations gradually increased to an overall mean value of 13-8 ± 1-2 ng/ml and no differences were observed in progesterone secretion between the groups.
Discussion
These results indicate that oestradiol benzoate treatment is capable of inducing an early, synchronous and predictable return to oestrus and ovulation in the weaned sow when given at an appropriate time. The majority of sows treated two days after weaning with 30 µg oestradiol benzoate/kg body weight returned to oestrus on or before Day 5, a time which compares favourably with the mean of 7-85 days recorded by Burger (1952) for Large White sows and with the results obtained in many commercial herds employing 3-week weaning (M.L.C., 1980). Although the interval of 3 days from oestradiol benzoate injection to overt oestrus in sows injected with 30 µg/kg on Day 2 is in agreement with published data (Rasbech, 1953; Dyck et al, 1979) , the marked reduction in fertility and prolonged oestrous periods associated with the previous use of synthetic oestrogens (de la Cerna, 1956; Rigor et al, 1968; Schmidt et al, 1968) were not observed.
The interval from weaning to oestradiol benzoate injection had a significant effect on the potential fertility of the sows in the present study. Injection of even a high dose of oestradiol benzoate on the day of weaning caused only a weak behavioural and visual oestrus 3 days later with no accompanying ovulation, whilst the same dose injected 1 or 2 days after weaning caused abnormal 'hyperactive' oestrous behaviour during which the sows were very excited and agitated and would not stand to be fully mated. Halving the dose of oestradiol benzoate removed these behavioural aberrations and produced a very strong standing oestrous response.
The reasons for the variability in ovarian responses to oestrogen treatment at different times after weaning are probably related to the patterns of gonadotrophin secretion present before treatment. Oestradiol benzoate treatment was, however, effective in stimulating the positive feedback mechanism to produce an LH surge and in inducing ovulation when given 2 days after weaning. Both the magnitude of the oestradiol benzoate-induced gonadotrophin responses and the differences between the 3-and 5-week weaned sows in the pattern of LH and FSH secretion were similar to those observed in untreated animals (Edwards & Foxcroft, 1983) . In addition to providing further evidence for an impairment of hypothalamic-pituitary activity with shortened lactations, this also demonstrates that the reduced ovulation rates after oestradiol benzoate treatment (12-2 at 5-weeks, 10-6 at 3-weeks compared to 17-3 at 5-weeks and 15-2 at 3-weeks in untreated sows: Edwards & Foxcroft, 1983) were not related to an oestrogen-induced depression of the concentrations of LH and FSH during the preovulatory surge. Furthermore the present study indicates that any reduction in gonadotrophin secretion during the surge in early-weaned sows is not in itself due to inadequate levels of oestradiol in the early post-weaning period (Edwards & Foxcroft, 1983) .
However, oestradiol treatment at or immediately after weaning did suppress the rise in basal LH secretion previously observed in untreated sows and as this rise in LH is postulated to be a major component of the trigger for follicular development, its complete or partial suppression probably limits follicular development and results in the observed reduction in ovulation or complete absence of follicular growth. Delaying treatment to Day 2 allows an adequate period of follicular stimulation such that ovulation rates at the synchronized oestrus are only marginally reduced when compared to those for untreated sows.
The suppression of FSH concentrations after the preovulatory gonadotrophin surge is atypical of untreated cyclic or weaned sows (Wilfinger, 1974; Edwards & Foxcroft, 1983 (Wilfinger, 1974) . If this is the case, then the suppression of FSH secretion associated with the present oestradiol benzoate regimen may lead to adverse responses if the sow returns to oestrus. Since all sows so far mated have conceived successfully this possibility has not been tested. Rasbech (1953) has shown that diethylstilboestrol treatment of weaned sows had a detrimental effect on conception rates at subsequent oestrous periods if conception did not occur at the induced oestrus, but no such effects were manifested when natural oestrogens were used.
The present study has therefore not only increased our limited knowledge of the basic endocrine interrelationships which control the return to oestrus after weaning but has also demonstrated the potential for the use of exogenous oestrogen in the weaned sow to synchronize the time of the preovulatory LH surge and hence ovulation. In this respect oestradiol benzoate treatment appears to have a potential application in commercial practice, in particular in those herds using artificial insemination although there is a consistent reduction in ovulation rate which could lead to unacceptably small litter sizes at term. However, the post-treatment concentrations of plasma oestradiol-17ß in the present studies were significantly higher at both dose levels of oestradiol benzoate employed than those previously reported for untreated cyclic and weaned sows in the preovulatory period (Shearer, Purvis, Jenkin & Haynes, 1972; de Wiel et al, 1981 ; Edwards & Foxcroft, 1983) , and a further reduction in the dose of oestradiol benzoate might minimize any detrimental side effects without causing a diminished ovuiatory response.
